JPH03216192A - Wf-19849 substance and preparation thereof - Google Patents
Wf-19849 substance and preparation thereofInfo
- Publication number
- JPH03216192A JPH03216192A JP2009196A JP919690A JPH03216192A JP H03216192 A JPH03216192 A JP H03216192A JP 2009196 A JP2009196 A JP 2009196A JP 919690 A JP919690 A JP 919690A JP H03216192 A JPH03216192 A JP H03216192A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- water
- absorption spectrum
- culture
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001327403 Kernia Species 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 4
- OZECDDHOAMNMQI-UHFFFAOYSA-H cerium(3+);trisulfate Chemical compound [Ce+3].[Ce+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O OZECDDHOAMNMQI-UHFFFAOYSA-H 0.000 claims abstract description 3
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 claims abstract description 3
- 238000001819 mass spectrum Methods 0.000 claims abstract description 3
- 238000002844 melting Methods 0.000 claims abstract description 3
- 230000008018 melting Effects 0.000 claims abstract description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims abstract 3
- 241000894006 Bacteria Species 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- 238000000862 absorption spectrum Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 241001212143 Cernia Species 0.000 claims description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 238000005481 NMR spectroscopy Methods 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 238000004809 thin layer chromatography Methods 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 abstract description 2
- 239000003429 antifungal agent Substances 0.000 abstract description 2
- 238000000354 decomposition reaction Methods 0.000 abstract description 2
- 238000004040 coloring Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 17
- 241000699670 Mus sp. Species 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000013076 target substance Substances 0.000 description 3
- 241000235349 Ascomycota Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000006783 corn meal agar Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 239000006877 oatmeal agar Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241000190562 Emericellopsis Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000001449 Tephrosia candida Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229950011321 azaserine Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 235000013495 cobalt Nutrition 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
- 229960004961 mechlorethamine Drugs 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000005142 microbroth dilution method Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 150000003377 silicon compounds Chemical class 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- JTERPZLSUHFRRP-UHFFFAOYSA-N sulfuric acid;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.OS(O)(=O)=O JTERPZLSUHFRRP-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
この発明は、抗真菌活性を有する新規なWF−1984
9物質に関するものであり、医療の分野で利用される。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] This invention provides novel WF-1984 having antifungal activity.
It concerns nine substances and is used in the medical field.
この発明は、新規なW F − 19849物質に関す
る。This invention relates to a novel WF-19849 substance.
さらに詳細には、この発明は抗真菌活性をイ了する新規
なW F − 19849物質およびその塩ならびにそ
れらの製造法を提供するものである。More specifically, the present invention provides novel WF-19849 substances and salts thereof that exhibit antifungal activity, and methods for producing them.
この発明は、下記の理化学的性質を有するWF=198
49物質およびその塩ならびにそれらの製造法よりなる
。This invention has the following physical and chemical properties: WF=198
It consists of 49 substances, their salts, and their production methods.
W F − 19849物質の理化学的性質■色および
性状:白色粉末
■融点=218〜229℃(分解)
■比旋光度.[α] ”,’= +54. 1° (C
=1.0H2O)
■分子式: C ,.H ..N ,O ,■質量スペ
クトル(FABMS):
■紫外線吸収スペクトル:
λH2°= 260n m
糖&X
λH,O゜OOINHC1=258nmm&X
λH,O゜00INa0H=2600m″一λ×
■赤外線吸収スペクトル
394(M+H)’
ν;3;= 3330.3180,2960,+635
.1595.1470.1385,+325.1290
,1240,1205,1168,1065,955,
820,795,715,640 cm■’H一核磁
気共鳴吸収スペクトル
δ(D ,O ) : 8. 67(IH,S),8.
19(IH,S), 6. 19(IH, d, J
= 3. 0Hz ), 4. 75(2H, o+)
, 4. 54(IH, d, J= 7. 3Hz
), 4. 08(IH, d, J一5.0セ).
2. 14(IH, m), l、57(IH,m),
1. 38(IH, m), 1. 05(3H,
d, J= 7.lセ), 1. 02(3H, t,
J= 7. 4セ),■+30一核磁気共鳴吸収スペ
クトル
δ(D ,O ) : 178.6, 172.6,1
57.9,155.1,150.9,142. 7,
121. 1, 91. 9, 83. 6, 76.
4, 60.2, 57. 2, 39. 0, 2
7. 9, 15. 6, 13. 5,[相]溶解性
:
易溶:水
難溶:メタノール,エタノール
不溶:クロロホルム,酢酸エチル
■呈色反応:
陽性:硫酸セリウム,ニンヒドリ
ン
@薄屑クロマトグラフィー:
Rf=0.6[担体:ンリ力ゲル(キーゼルゲル60
F’−254:商品名,メルク社製)展開溶媒:イソブ
口バノール:水
=7:3
Rf=0.3[担体・シリカゲル(キーゼルゲル60F
−254:商品名,メルク社製)展開溶媒.n−ブタノ
ール:酢酸
:水=4:1:2
■酸、塩基性・両性
この発明のW F−19849物質は、例えばケルニア
属に属するW F − 14Hl49物質生産菌のよう
なWF − 19849物質生産菌を培地に培養し、得
られる培養物からW F − 19849物質を分離採
取することにより製造することができる。Physical and chemical properties of W F-19849 substance ■ Color and properties: white powder ■ Melting point = 218-229°C (decomposition) ■ Specific optical rotation. [α] ”,'= +54.1° (C
=1.0H2O) ■Molecular formula: C,. H. .. N , O , ■ Mass spectrum (FABMS): ■ Ultraviolet absorption spectrum: λH2° = 260 nm Sugar & X λH, O゜OOINHC1 = 258 nm &ν;3;= 3330.3180,2960,+635
.. 1595.1470.1385, +325.1290
,1240,1205,1168,1065,955,
820,795,715,640 cm■'H nuclear magnetic resonance absorption spectrum δ(D,O): 8. 67 (IH, S), 8.
19 (IH, S), 6. 19 (IH, d, J
= 3. 0Hz), 4. 75 (2H, o+)
, 4. 54 (IH, d, J= 7.3Hz
), 4. 08 (IH, d, J-5.0ce).
2. 14 (IH, m), l, 57 (IH, m),
1. 38 (IH, m), 1. 05 (3H,
d, J=7. lse), 1. 02(3H, t,
J=7. 4th),■+30-Nuclear magnetic resonance absorption spectrum δ(D,O): 178.6, 172.6,1
57.9, 155.1, 150.9, 142. 7,
121. 1, 91. 9, 83. 6, 76.
4, 60.2, 57. 2, 39. 0, 2
7. 9, 15. 6, 13. 5, [Phase] Solubility: Easily soluble: Slightly soluble in water: Insoluble in methanol, ethanol: Chloroform, ethyl acetate ■ Color reaction: Positive: Cerium sulfate, ninhydrin @ Thin dust chromatography: Rf = 0.6 [Carrier: Nuri force Gel (Kiesel Gel 60
F'-254: Trade name, manufactured by Merck & Co.) Developing solvent: Isobanol: Water = 7:3 Rf = 0.3 [Carrier: Silica gel (Kieselgel 60F)
-254: Trade name, Merck & Co., Ltd.) developing solvent. n-butanol:acetic acid:water=4:1:2 ■Acidic, basic/amphoteric The WF-19849 substance of the present invention can be used to produce WF-19849 substances, such as WF-14Hl49 substance-producing bacteria belonging to the genus Cernia. It can be produced by culturing bacteria in a medium and separating and collecting the WF-19849 substance from the resulting culture.
この発明で使用するW F − 19849物質生産菌
のうち、この発明者等が岩手県盛岡市で採取した土壌試
料から新たに分離した菌株(F − 19849株と番
号を付す)は、以下に示すような菌学的性質を有する。Among the WF-19849 substance-producing bacteria used in this invention, the strain newly isolated by the inventors from a soil sample collected in Morioka City, Iwate Prefecture (numbered as strain F-19849) is shown below. It has similar mycological properties.
種一クーの培地上での41
本菌株は、麦芽エキス寒天培地およびジャガイモブドウ
糖寒天培地等の各種培地上で抑制的に生育し、オレンジ
色味白色から薄いオレンジ色の集落を形成した。また、
オートミール寒天培地、コーンミール寒天培地、および
YpS s寒天培地上で2〜4週間培養する事により、
閉鎖型の子嚢殻(テレオモルフ)とアン不口型分生子(
アナモルフ)の形成が観察された。以下に本菌株の形態
、培養上および生理的な性質を示す。41 on Seed Ichiku medium This strain grew suppressed on various media such as malt extract agar medium and potato glucose agar medium, and formed orange-white to pale orange colonies. Also,
By culturing on oatmeal agar, cornmeal agar, and YpS agar for 2 to 4 weeks,
Closed ascus shell (teleomorph) and unmouthed conidia (
The formation of anamorphs was observed. The morphology, culture and physiological properties of this strain are shown below.
培養上の特徴
各種培地上での培養性状を表1に示す。ジャガイモ・ブ
ドウ糖寒天培地上の中心に接種し、25℃で2週間培養
した時の生育は、極めて抑制的で、直径1.5cmにま
で広がった。集落の表面は、しわ状に隆起し、白色から
薄いオレンジ色であった。Culture characteristics Table 1 shows the culture characteristics on various media. When it was inoculated onto the center of a potato glucose agar medium and cultured at 25°C for 2 weeks, growth was extremely suppressed and it spread to a diameter of 1.5 cm. The surface of the settlement was raised in the form of wrinkles and was white to pale orange in color.
集落裏面は薄いオレンジ色。分生子構造・子嚢殻は、形
成されなかった。同様の培養をオートミール寒天培地上
で行った時の生育は、同様に抑制的であった(直径1.
5〜2.0cm)。集落表面は、やや盛り上がり、オレ
ンジ色味白色から薄(嵐オレンジ色であった。集落裏面
は、薄いオレンジ色。分生子構造および子嚢殻が形成さ
れた。The back side of the village is pale orange. No conidial structure or asci were formed. Growth when similar cultures were grown on oatmeal agar was similarly suppressive (1.
5-2.0cm). The surface of the colony was slightly raised and orange-white to pale (storm orange). The underside of the colony was pale orange. Conidial structures and ascus shells were formed.
形態的特徴
形態的特徴の観察は、主としてコーンミール寒天培地上
等での生育をもとに行った。子嚢殻は、埋没性または表
在性、単独で、開口部を持たず(閉子嚢殻)、球形また
は亜球形、明るい茶色からオレンジ色を示し、直径は7
0−150(−200)μ−である。Morphological Characteristics Observation of morphological characteristics was mainly based on growth on cornmeal agar medium. The asci can be buried or superficial, singly, without an opening (cleistocele), spherical or subglobular, light brown to orange in color, and 7 mm in diameter.
0-150(-200)μ-.
培養初期の子嚢殻は側毛様の菌糸に覆われる力《、成熟
時には菌糸が消失するため裸出する。子嚢殻壁は4〜6
層の細胞からなり、子嚢殻中に子嚢が散在する。子嚢は
、一重壁子嚢で、消失性、亜球形から倒卵形、直径9−
15(−18)μ腸で、8個の子嚢胞子を内生ずる。子
嚢胞子は、淡色から薄い茶色で、集合すると赤茶色を示
し、滑面、1細胞、顕著な腎臓形で、4−6(−7)X
3. 5−5μ鵬である。子嚢胞子の両端には、それぞ
れ1個の発芽孔をもつ。F19849株のアナモルフは
、ほうき状の分生子柄とアンネロ型分生子からなる。分
生子柄は無色、滑面、隔壁があり、単独または短い分生
子柄束として立ち上がる。これらは、2〜4回分技し、
長さ30−50(−60)μm1幅10−20(−30
)μmのほうき状になる。At the early stage of culture, the ascus shell is covered with lateral hair-like hyphae, but when it matures, the hyphae disappear and it becomes bare. The ascus wall is 4-6
It consists of layers of cells, with ascus scattered within the ascus shell. Asci are single-walled, effaced, subglobose to obovate, 9-diameter.
It has a 15 (-18) μ intestine and produces 8 ascospores. Ascospores are pale to light brown, reddish-brown when aggregated, smooth, 1-celled, prominently kidney-shaped, 4-6(-7)X
3. It is 5-5 μpeng. Each end of the ascospore has one germination hole. The anamorph of strain F19849 consists of broom-shaped conidiophores and Annelo-type conidia. Conidiophores are colorless, smooth, and septate, erecting singly or in short conidiophore bundles. These techniques are done 2 to 4 times,
Length 30-50 (-60) μm 1 Width 10-20 (-30
) μm broom-like shape.
分枝の大きさは8−10X3−5μmで、それぞれがさ
らに3〜5本の分技を生じる。分生子柄の頂端細胞は、
無色、滑而、円筒形から桿形、8−17(−25)Xi
−3(−3.5)μmのアン不ロフォアになる。分生子
は無色、滑而で、1細胞、倒卵形から倒洋梨形、基部は
裁断状で、4−8XI. 5−3. 5μmの大きさで
ある。これらは、連鎖せず、分生子柄(束)の先端で直
径30−70(−100)μmの分生子魂を形成する。The size of the branches is 8-10 x 3-5 μm, each giving rise to 3-5 further branches. The apical cell of the conidiophore is
Colorless, smooth, cylindrical to rod-shaped, 8-17(-25)Xi
-3 (-3.5) μm anthrophore. Conidia are colorless, smooth, 1 cell, obovate to obovate pear-shaped, base truncated, 4-8XI. 5-3. The size is 5 μm. These are not linked and form a conidial soul with a diameter of 30-70 (-100) μm at the tip of the conidiophore (bundle).
栄養菌糸は隔壁を持ち、無色、滑面で分枝する。菌糸細
胞は円筒形から樽型または楕円形で、幅2−5(−7)
μ脂である。The vegetative hyphae are septate, colorless, smooth and branched. Hyphal cells are cylindrical to barrel-shaped or oval, 2-5 (-7) wide.
It is mu fat.
厚膜胞子は、単独または連続して、豊富に形成され、亜
球形から広楕円形で、直径は8−12μmであった。Chlamydospores were abundantly formed, singly or in series, subglobose to broadly ellipsoidal, and 8-12 μm in diameter.
生理学的特徴
F−19849株は2〜34℃の範囲で生育可能で、生
育最適温度は23〜26゜Cであった(ジャガイモ・ブ
ドウ糖寒天上で測定した)。Physiological Characteristics Strain F-19849 can grow in the range of 2-34°C, and the optimum temperature for growth was 23-26°C (measured on potato glucose agar).
以上の特徴およびアルックス(^rx. J.^. v
an)著の、ザ・ゼネラ・オブ・フンギ一一−スボルレ
イティング・イン・ピュア・カルチ二ア( The g
enera or Fungi−−Sporulati
ng in Pure Culture)の第3版、第
315頁記載、マローおよびケイン(Mailoch,
D. , and R. F. Cain)著のザ・
ジーナス・ケノレニア(The genus Kern
ia) [カナディアン3ジャーナル・オブ・ボタニ
イ( Can. J. Bot. ),第49巻、第8
55−第867頁, 1971年]記載、宇田川および
古谷著のエメリセロプシス・スファエロスボラ・アンド
・ケルニア・ベルピアナ,トウー・二二一・ンイノレー
ポノレ不・タレイストテシアノレ・アスコマイセテス(
Emericellopsis sphaerospo
ra and Kernia peruviana.T
vo new soil−borne cleisto
thecial AscoIIlycetes)[マイ
コタクソン(Mycotaxon)第18巻、第291
−第301頁, 1988年]記載から、P−198
49株は、子嚢菌類ケルニア属(Kernia Nie
uvland)に所属すると思われた。従って、この生
産菌株を、ケルニア・エスピー・F−19849(Ke
rnia sp. F−19849)と命名した。The above characteristics and Alux (^rx. J.^. v
The General of Funghi 11 - Svolrating in Pure Carcinia (The g
enera or Fungi--Sporulati
ng in Pure Culture), 3rd edition, page 315, Mailoch and Kane (Mailoch,
D. , and R. F. Cain)
The genus Kern
ia) [Canadian 3 Journal of Botany (Can. J. Bot.), Volume 49, No. 8
55-867, 1971], Udagawa and Furuya, Emeryseropsis sphaerosvora and Cernia velpiana, Tou 221 Ninoleponorefu Thaleistotesianore Ascomycetes (
Emericellopsis sphaerospo
ra and Kernia peruviana. T
vo new soil-borne cleisto
thecial AscoIIlycetes) [Mycotaxon, Vol. 18, No. 291
-Page 301, 1988], P-198
49 strains belong to the ascomycete genus Kernia.
uvland). Therefore, this production strain was used as Kernia sp.
rnia sp. F-19849).
表
1
F
9849
株の培養上の特徴
上記の侍l11、25℃で、14日関1a#il:fl
察しk0色名の記載1j、メズエン・ハンドブック−1
プ・カラー(MeLhuen Handbook
of Colour)の!3mIz52N+&とCI
,7行,&0
このケルニア・エスピー・F−19849株は、工業技
術院微生物工業技術研究所に微工研閑寄第11107号
として平成元年11月14日に寄託されている。Table 1 Culture characteristics of the F 9849 strain Samurai 11 above, 14 days at 25°C Seki 1a#il:fl
Inspection k0 color name description 1j, mezuen handbook-1
MeLhuen Handbook
of Color)! 3mIz52N+& and CI
, line 7, &0 This Kernia sp. strain F-19849 has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology as Microtechnology Research Grant No. 11107 on November 14, 1989.
この発明で使用するIP−19849物質生産菌は、例
えばX線、紫外線等の照射処理、例えばナイトロジエン
・マスタード、アザセリン、亜硝酸、2−7ミノプリン
、N−メチルーN−ニトロ一N−ニトロソグアニジン(
NTG)等の変異誘起剤による処理、ファ−ジ接触、形
質転換、形質導入、接合等の通常用いられる菌種変異処
理方法により、YF−19849物質の生産能を高める
ことができる。The IP-19849 substance producing bacteria used in this invention can be treated with irradiation such as X-rays or ultraviolet rays, such as nitrogen mustard, azaserine, nitrous acid, 2-7 minoprine, N-methyl-N-nitro-N-nitrosoguanidine. (
The production ability of the YF-19849 substance can be increased by commonly used bacterial species mutation treatment methods such as treatment with a mutagenic agent such as NTG, phage contact, transformation, transduction, and conjugation.
ケルニア属に属するWF−19849物質生産菌を培地
に培養することにより行なわれるYF−19849物質
の生産は原則的には一般微生物の培養方法に準ずるが、
通常は液体培地による深部培養法が有利である。培養に
用いられる培地としては、ケルニア属に属するWF−1
9849物質生産菌が利用する栄養源を含有する培地で
あればよい。すなわち、合成培地、半合成培地あるいは
天然培地が用いられ、培地組成は炭素源としては、例え
ばグルコース、/ユークロース、マルトース、グリセリ
ン、でん粉、液化でん粉等が用いられ、窒素源として、
例えば肉エキス、カセイン加水分解物、ベブトン、グル
テンミール、コーンミール、綿実粉、大豆粉、コーンス
チーブリカー ピーナツパウダー、小麦胚芽、乾燥酵母
、酵母エキス、尿素、りん酸アンモニウム等が用いられ
る。このほか、例えばりん酸水素2ナトリウム、りん酸
2水素カリウム、塩化マグネシウム、硫酸マグネ/ウム
、炭酸カルシウム、ヨウ化ナトリウム、塩化コバルト6
水塩等の無機塩も必要に応じて培地に添加される。The production of YF-19849 substance, which is carried out by culturing WF-19849 substance-producing bacteria belonging to the genus Cernia in a medium, is in principle based on the culture method of general microorganisms.
Deep culture methods using liquid media are usually advantageous. The medium used for culture is WF-1, which belongs to the genus Kernia.
Any medium may be used as long as it contains a nutrient source used by the 9849 substance producing bacteria. That is, a synthetic medium, a semi-synthetic medium or a natural medium is used, and the medium composition includes, for example, glucose, euculose, maltose, glycerin, starch, liquefied starch, etc. as a carbon source, and as a nitrogen source,
For example, meat extract, casein hydrolyzate, bebutone, gluten meal, corn meal, cottonseed flour, soybean flour, corn steep liquor, peanut powder, wheat germ, dried yeast, yeast extract, urea, ammonium phosphate, etc. are used. In addition, examples include disodium hydrogen phosphate, potassium dihydrogen phosphate, magnesium chloride, magnesium sulfate, calcium carbonate, sodium iodide, cobalt 6 chloride.
Inorganic salts such as aqueous salts are also added to the medium as necessary.
また培養中発泡の著しい時には、例えば大豆曲、亜麻仁
油等の植物油、オクタデカノール、テトラデカノール、
ヘブタノール等の高級アルコール類、シリコン化合物等
の消泡剤を適宜添加すればよい。In addition, when foaming is significant during culturing, for example, vegetable oils such as soybean oil, linseed oil, octadecanol, tetradecanol, etc.
Higher alcohols such as hebutanol and antifoaming agents such as silicon compounds may be added as appropriate.
培養潟度は23〜26゜C前後が適当であり、培養容量
の増大に従って適宜種培養を行なうと好結果が得られる
ことが多い。本培養の培養時間は50〜300時間位が
適当であり、培地が濃厚のなるのに従って、培養時間を
さらに延長してもよい。The appropriate culture temperature is around 23 to 26°C, and good results are often obtained if seed culture is carried out as appropriate as the culture volume increases. The appropriate culture time for the main culture is about 50 to 300 hours, and the culture time may be further extended as the medium becomes more concentrated.
以上述べた培養条件は使用生産菌株の特性に応じてそれ
ぞれの最適の条件を選択して使用される。The culture conditions described above are selected and used depending on the characteristics of the production strain used.
次に、培養により生成したWFl9849物質は通常、
培養物中の菌体内に蓄積されることが多いので、一般に
は遠心分離、ろ過等の手段により、菌体およびろ液(上
澄液)に分離した後閑体から一般抗生物質の製造に用い
られる手段により分離、精製および採取される。すなわ
ち、菌体を溶媒に溶解させ目的物質を溶媒抽出した後、
液性変換、例えば陰イオン交換樹脂、陽イオン交換樹脂
、非イオン性吸着樹脂等の樹脂による処理、例えば活性
炭、けい酸、ソリ力ゲル、アルミナ、セルロース等の吸
着剤による処理、結晶化、再結晶等の手段を任意の順序
に組み合わせまたは反復して適用することにより、目的
物質であるWF−19849物質を分離、精製すること
ができる。Next, the WFl9849 substance produced by culture is usually
Since it often accumulates within the bacterial cells in culture, it is generally separated into bacterial cells and filtrate (supernatant liquid) by means such as centrifugation or filtration, and then used in the production of general antibiotics from the empty cells. It is separated, purified and collected by means. That is, after dissolving the bacterial cells in a solvent and extracting the target substance with the solvent,
Liquid conversion, such as treatment with resins such as anion exchange resins, cation exchange resins, and nonionic adsorption resins, treatment with adsorbents such as activated carbon, silicic acid, sori gel, alumina, and cellulose, crystallization, and reuse. By combining or repeatedly applying means such as crystallization in any order, the target substance WF-19849 substance can be separated and purified.
遊離の形で得られた11F−19849物質は、水酸化
ナトリウム、水酸化カリウム等の塩基を作用させて所望
の塩に導くことができる。The 11F-19849 substance obtained in free form can be converted into a desired salt by reacting with a base such as sodium hydroxide or potassium hydroxide.
この発明の目的物質であるWF−19849物質は、経
口用、非経口用あるいは外用に適した有機もしくは無機
の固体状または液状の憤用担体と混合して、慣用の医薬
製剤、例えばカプセル剤、錠剤、顆粒剤もしくは坐剤の
ような固形製剤、軟膏のような半固形製剤または液剤も
しくは乳剤のような液状製剤の形で使用され得る。The substance WF-19849, which is the object substance of the present invention, can be mixed with an organic or inorganic solid or liquid carrier suitable for oral, parenteral or external use, and prepared into a conventional pharmaceutical formulation, such as a capsule. It may be used in the form of solid preparations such as tablets, granules or suppositories, semi-solid preparations such as ointments or liquid preparations such as solutions or emulsions.
なお、上記製剤中には、安定化剤、湿潤剤、乳化剤等の
慣用の添加剤が適宣含まれていてもよい。In addition, the above-mentioned formulation may contain appropriate amounts of conventional additives such as stabilizers, wetting agents, and emulsifiers.
目的化合物〔l〕の投与量は患者の年令、体重、症状等
にもよるが通常一回約0.1■ないし1000■の範囲
で投与される。The dose of the target compound [1] depends on the patient's age, weight, symptoms, etc., but is usually administered in the range of about 0.1 to 1000 μ at a time.
この発明の目的物質であるIIIP−19849物質お
よび医薬として許容されるその塩は、以下の試験結果か
らも明らかなように、抗真菌活性を有し、人および動物
の抗真菌剤として有用である。Substance IIIP-19849 and its pharmaceutically acceptable salts, which are the target substances of this invention, have antifungal activity and are useful as antifungal agents for humans and animals, as is clear from the following test results. .
(1)抗菌力試験
抗菌作用
WF−19849物質の抗菌作用を下記の96凹部マル
チ・トレーを使用するマイクロ・ブロス希釈法常法によ
り測定した。(1) Antibacterial activity test Antibacterial activity The antibacterial activity of the WF-19849 substance was measured by the conventional micro-broth dilution method using a 96-concave multi-tray as described below.
イーグルの最小必須培地(E.MEM)で菌を一夜培養
し、培養ブロスを希釈することにより、試験菌懸濁I&
(生閑数2X 10’個/m1)を調整した。Test bacterial suspensions were prepared by culturing the bacteria overnight in Eagle's minimum essential medium (E.MEM) and diluting the culture broth.
(2×10' pieces/m1) was adjusted.
WF−19849物質のE, MEM (100μ!)
中連続濃度段階希釈溶液をマルチ・トレーの凹部に加え
た。E, MEM of WF-19849 substance (100μ!)
Medium serial concentration serially diluted solutions were added to the wells of the multi-tray.
四部に試験閑懸濁液100μ!を加えた後、マルチ・ト
レーを5%炭酸ガス雰囲気中、30°Cで40時間加温
した後、最小発育阻止濃度(ffilc)を測定した。100μ of test suspension in four parts! After adding , the multi-tray was heated at 30°C for 40 hours in a 5% carbon dioxide atmosphere, and then the minimum inhibitory concentration (ffilc) was measured.
その結果を表2に示す。The results are shown in Table 2.
表2 IP−19849の抗菌活性試験動物
生後4週齢、体重各18〜21gのICR系マウス、1
群がマウス5匹よりなる。Table 2 Antibacterial activity test of IP-19849 Animals 4 weeks old, ICR mice weighing 18-21 g each, 1
Groups consisted of 5 mice.
試験法
生理食塩水に懸濁した病原菌カンジタ・Tルど力冫ス(
Candida albicans)FI’633を1
匹当たり2X 10@個の生菌数になるように、マウス
の側尾静脈に注射した。感染(側尾静脈に注射)1時間
後、WF−19849物質の生理食塩水溶液を皮下注射
によりマウスに投与した。この皮下注射を感染の翌日か
ら1日1回、3日間繰り返した。感染後l1日目のマウ
スの生存匹数を観察し、得られた結果を表3に示す。Test method The pathogenic bacteria Candida T.
Candida albicans) FI'633 1
The mice were injected into the lateral tail vein at a viable count of 2×10 cells per mouse. One hour after infection (injection into the lateral tail vein), a saline solution of the WF-19849 substance was administered to the mice by subcutaneous injection. This subcutaneous injection was repeated once a day for 3 days starting the day after infection. The number of surviving mice was observed on day 11 after infection, and the results are shown in Table 3.
表3
(2)毒性試験
YF−19849物質の急性毒性を生後4週齢の雌マウ
スについて1回静脈注射により測定し、投与量320m
g/kgで死亡例は認められなかった。Table 3 (2) Toxicity test The acute toxicity of YF-19849 substance was measured by intravenous injection once in 4-week-old female mice, and the dose was 320 m
No deaths were observed at 100 g/kg.
以下、実施例によりこの発明を説明する。 The present invention will be explained below with reference to Examples.
シュークロース4%,綿実粉2%,モラティン1%,ベ
ブトン1%,リン酸カリウム0.2%.炭酸;ルシウム
02%を含む種培地(+6[1ml)を500mlXル
レンマイヤーフラスコ2個にそれぞれ中に注ぎ121℃
、30/AIiflll&菌する。ケルニア・エスビー
F9849株(微工研菌寄第11107号)の斜面培養
物1白金耳を各培地に接種し、25℃で4日間振とぅ培
養する。4% sucrose, 2% cottonseed flour, 1% moratin, 1% bebutone, 0.2% potassium phosphate. Carbonate: Pour seed medium (+6 [1 ml) containing 02% lucium] into two 500 ml X Lullenmeyer flasks at 121°C.
, 30/AIifllll&bacteria. One platinum loop of a slant culture of Kernia SB strain F9849 (Feikoken Bacteria No. 11107) was inoculated into each medium, and cultured with shaking at 25°C for 4 days.
パイン・デIクス#3 3%,ンユークロース1%,も
ろこし粉1%,モラティンl%,硝酸ナトリウム02%
,リン酸カリウム0.1%.硫酸マグ不シウム12水塩
0. OS%,塩化カリウム0,05%,炭酸力ルンウ
ム0.2%およびアデヵノール(消泡剤,商品名,旭電
化社製)0.05%を含む生産培地(2o1を3(Jl
容ジャー・ファーメンターに注ぎ、121℃,30分間
滅菌する。上記で得られた種培養物(320ml)を生
産培地に接種し200rp mの撹拌、毎分2(a c
v通気下に25゜Cで5日間培養する。Pine de Ix #3 3%, Nucleose 1%, Sorghum flour 1%, Moratin 1%, Sodium nitrate 02%
, potassium phosphate 0.1%. Magunium sulfate decahydrate 0. Production medium (2 o1 to 3 (Jl
Pour into a jar/fermenter and sterilize at 121°C for 30 minutes. The seed culture (320 ml) obtained above was inoculated into the production medium, stirred at 200 rpm, and stirred at 2 (ac) per minute.
Incubate for 5 days at 25°C under aeration.
このようにして得られる培養物(5Ql)にケイ藻±(
Ikg)を加え濾過する。濾液(36N)を陰イオン交
換樹脂ダウェノクスIX 2 (O H−g,商品名,
米国ダウケミカル社製)のカラム(6g)に付す。カラ
ムを水洗(】2β)して、0. 5M塩化ナトリウムで
溶出する。溶出液(101)を活性炭素(和光純薬工業
社製)を使用するカラム(21)に付す。カラムを水(
41)で洗浄して50%アセトン水で溶出する。溶出液
(61)を減圧下に濃縮しアセトンを除去した後に、吸
着樹脂S P −207(商品名,三菱化成工業社製)
のカラム(21)に付す。カラムを水(4g)で洗浄し
て、50%メタノール水で溶出する。溶出液(61)を
減圧下に濃縮し、メタノールを除去した後に、陽イオン
交換CMセファディクスC − 25(商品名,ファル
マシア社製)のカラム(0.5N)に付す。カラムを水
(1!)で洗浄して、0.08M塩化ナトリウムで溶出
する。溶出液(1g)をS P − 207カラム(1
00ml)に付し、水( 3oov )で洗浄して50
%メタノール水で溶出する。溶出液( 2DDd )を
減圧下に濃縮してメタノールを除去した後、凍結乾燥し
てWF19f!149物質(620mg)を白色粉末と
して得る。The culture thus obtained (5Ql) was added to the diatom ±(
Ikg) and filter. The filtrate (36N) was treated with anion exchange resin Dawenox IX 2 (OH-g, trade name,
The mixture was applied to a column (6 g) manufactured by Dow Chemical Co., USA. The column was washed with water (]2β) and 0. Elute with 5M sodium chloride. The eluate (101) is applied to a column (21) using activated carbon (manufactured by Wako Pure Chemical Industries, Ltd.). Dip the column into water (
Wash with 41) and elute with 50% acetone water. After concentrating the eluate (61) under reduced pressure to remove acetone, adsorption resin SP-207 (trade name, manufactured by Mitsubishi Chemical Industries, Ltd.) was applied.
column (21). Wash the column with water (4 g) and elute with 50% methanol/water. The eluate (61) is concentrated under reduced pressure to remove methanol, and then applied to a column (0.5N) of cation exchange CM Sephadix C-25 (trade name, manufactured by Pharmacia). Wash the column with water (1!) and elute with 0.08M sodium chloride. The eluate (1 g) was applied to an SP-207 column (1 g).
00ml), washed with water (3oov) and diluted with 50ml
Elute with % methanol water. The eluate (2DDd) was concentrated under reduced pressure to remove methanol, and then lyophilized to give WF19f! 149 substance (620 mg) is obtained as a white powder.
Claims (1)
質およびその塩類。 (1)色および性状:白色粉末 (2)融点:218〜229℃(分解) (3)比旋光度:〔α〕^2^0_D=+54.1゜(
C=1.0H_2O) (4)分子式:C_1_6H_2_3N_7O_5(5
)質量スペクトル(FABMS):394(M+H)^
+(6)紫外線吸収スペクトル: ▲数式、化学式、表等があります▼ (7)赤外線吸収スペクトル ν^K^B^r_m_a_x=3330、3180、2
960、1635、1595、1470、1385、1
325、1290、1240、1205、1168、1
065、955、820、795、715、640cm
^−^1(8)^1H−核磁気共鳴吸収スペクトル δ(D_2O):8.67(1H、S)、8.19(1
H、S)、6.19(1H、d、J=3.0Hz)、4
.75(2H、m)、4.54(1H、d、J=7.3
Hz)、4.08(1H、d、J=5.0Hz)、2.
14(1H、m)、1.57(1H、m)、1.38(
1H、m)、1.05(3H、d、j=7.1Hz)、
1.02(3H、t、J=7.4Hz)、(9)^1^
3C−核磁気共鳴吸収スペクトルδ(D_2O):17
8.6、172.6.157.9、155.1、150
.9、142.7、121.1、91.9、83.6、
76.4、60.2、57.2、39.0、27.9、
15.6.13.5、(10)溶解性: 易溶:水 難溶:メタノール、エタノール 不溶:クロロホルム、酢酸エチル (11)呈色反応: 陽性:硫酸セリウム、ニンヒドリン (12)薄層クロマトグラフィー: Rf=0.6〔担体:シリカゲル(キーゼルゲル60F
−254:商品名、メルク社製)展開溶媒:イソプロパ
ノール:水=7:3 Rf=0.3〔担体:シリカゲル(キーゼルゲル60F
−254:商品名、メルク社製)展開溶媒:n−ブタノ
ール:酢酸:水=4:1:2 (13)酸、塩基性:両性 [2]ケルニア属に属するWF−19849物質生産菌
を培養し、その培養物からWF−19849 物質を採取することを特徴とするWF−19849物質
の製造法。 [3]ケルニア属に属するWF−19849物質生産菌
がケルニア・エスピーである特許請求の範囲第2項記載
のWF−19849物質の製造法[Scope of Claims] [1] WF-19849 substance and its salts having the following physical and chemical properties. (1) Color and properties: white powder (2) Melting point: 218-229°C (decomposed) (3) Specific rotation: [α]^2^0_D=+54.1°(
C=1.0H_2O) (4) Molecular formula: C_1_6H_2_3N_7O_5(5
) Mass spectrum (FABMS): 394 (M+H)^
+ (6) Ultraviolet absorption spectrum: ▲Mathematical formulas, chemical formulas, tables, etc.▼ (7) Infrared absorption spectrum ν^K^B^r_m_a_x=3330, 3180, 2
960, 1635, 1595, 1470, 1385, 1
325, 1290, 1240, 1205, 1168, 1
065, 955, 820, 795, 715, 640cm
^-^1(8)^1H-Nuclear magnetic resonance absorption spectrum δ(D_2O): 8.67(1H,S), 8.19(1
H, S), 6.19 (1H, d, J = 3.0Hz), 4
.. 75 (2H, m), 4.54 (1H, d, J = 7.3
Hz), 4.08 (1H, d, J=5.0Hz), 2.
14 (1H, m), 1.57 (1H, m), 1.38 (
1H, m), 1.05 (3H, d, j=7.1Hz),
1.02 (3H, t, J=7.4Hz), (9)^1^
3C-Nuclear magnetic resonance absorption spectrum δ(D_2O): 17
8.6, 172.6.157.9, 155.1, 150
.. 9, 142.7, 121.1, 91.9, 83.6,
76.4, 60.2, 57.2, 39.0, 27.9,
15.6.13.5, (10) Solubility: Easily soluble: Slightly soluble in water: Methanol, ethanol Insoluble: Chloroform, ethyl acetate (11) Color reaction: Positive: Cerium sulfate, ninhydrin (12) Thin layer chromatography: Rf=0.6 [Carrier: Silica gel (Kiesel gel 60F
-254: Trade name, manufactured by Merck & Co.) Developing solvent: Isopropanol: Water = 7:3 Rf = 0.3 [Carrier: Silica gel (Kieselgel 60F
-254: Product name, Merck & Co.) Developing solvent: n-butanol: acetic acid: water = 4:1:2 (13) Acid, basicity: amphoteric [2] Cultivate WF-19849 substance-producing bacteria belonging to the genus Kernia. and collecting the WF-19849 substance from the culture. [3] The method for producing the WF-19849 substance according to claim 2, wherein the WF-19849 substance-producing bacterium belonging to the genus Cernia is Cernia sp.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009196A JPH03216192A (en) | 1990-01-17 | 1990-01-17 | Wf-19849 substance and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009196A JPH03216192A (en) | 1990-01-17 | 1990-01-17 | Wf-19849 substance and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03216192A true JPH03216192A (en) | 1991-09-24 |
Family
ID=11713756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009196A Pending JPH03216192A (en) | 1990-01-17 | 1990-01-17 | Wf-19849 substance and preparation thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03216192A (en) |
-
1990
- 1990-01-17 JP JP2009196A patent/JPH03216192A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR830002801B1 (en) | Process for preparing antihypercholesteramic agent monacolink and its preparation | |
JPH03184921A (en) | New polypeptide compound and preparation thereof | |
JPH0285296A (en) | Fr901228 substance and preparation thereof | |
US7939081B2 (en) | Method for producing cercosporamide | |
RU2716590C1 (en) | Strain of basidiomycete inonotus obliquus - producer of melanin pigment possessing antiviral and antitumoral activity | |
WO2010122669A1 (en) | Novel compound amycolamicin, method for production thereof, and use thereof | |
JPH03216192A (en) | Wf-19849 substance and preparation thereof | |
JP4380913B2 (en) | Novel FT-0554 substance and production method thereof | |
KR970002492B1 (en) | Novel tripedtide derivatives | |
JP2002509444A (en) | WF14573 or a salt thereof, their production method and use | |
JPH07277971A (en) | Antitumor agent, selective cytotoxic agent for human tumor cell, microbial strain producing heptelidic acid chlorohydrin and its production | |
JPH0341089A (en) | Physiologically active substance 3127 | |
JP2000086627A (en) | Antibacterial substance be-54476 and its production | |
JPH08259585A (en) | Physiologically active substance fr 183783 | |
WO2009116604A1 (en) | Wickerol and process for production thereof | |
JPH04224559A (en) | Arterialization-inhibiting substance fr-901448 and fr-901449 | |
JPS5889187A (en) | No14-a substance and its preparation | |
JPH05239023A (en) | Physiologically active substance mbp039-06 and its production | |
WO1995018142A1 (en) | Wf15604 substances | |
JPH0356494A (en) | Fr901308 substance and production thereof | |
JPH09100261A (en) | Antimicrobial substance be-44651 | |
JPH06135979A (en) | New substance nk374200, its production and use thereof | |
JPS63162697A (en) | Novel antibiotic substance sf-2415a3 and sf-2415b3 and production thereof | |
JPH1112296A (en) | Antifungal compound afa0424 | |
JPS6027390A (en) | Fr-900216 substance and its preparation |